Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.
Message: During the three and nine months ended February 29, 2012, TPL entered into licen
Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Re: During the three and nine months ended February 29, 2012, TPL entered into licen
"During the three and nine months ended February 28, 2013, PDS entered into licensing agreements with third parties, pursuant to which PDS recognized revenues of $0 and $4,820,000, respectively."